A new type of contraceptive product – subcutaneous injectables, widely known by Pfizer’s brand name Sayana® Press – can be safely and easily administered by community health workers and through home- and self-injection where authorized. Sayana® Press has the potential to bring more options for contraception closer to consumers, giving consumers the power to decide where, when, and how they want it.
PSI launched our first social marketing programs for injectable contraception in 1995 to expand the range of family planning options available to women. In 2017, we distributed nearly 9 million injectable contraceptives globally. Today, PSI and partners are developing health markets and systems to include Sayana® Press in 11 countries.
Read more about our Sayana® Press work in the infographic below.
Infographic by Dominique Brown, Creative Manager, PSI